Drawing for XN CAL

USPTO serial 85147651

XN CAL

Reviewed by CopyMark Law Group

Reg. 4315467Status 800Registered
Filing date
Status date
Registration date
Apr 9, 2013
Examiner
ROSSMAN, WILLIAM M
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with XN CAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mainak H. Mehta

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP525 B Street, Suite 2200San Diego, CA 92101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ chemical preparations for scientific purposes in the nature of stain solutions for clinical laboratory use, stain solutions for hematology analysis for clinical laboratory use, stain solutions for reticulocyte analysis for clinical laboratory use, stain solutions for urinalysis for clinical laboratory use, and stain solutions for immunoassay for clinical laboratory use ]SECTION 8 - CANCELLED—
005Sanitary preparations for medical purposes; [ Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; medical and veterinary diagnostic reagents for hematology analysis; medical and veterinary diagnostic reagents for white blood cell analysis; medical and veterinary diagnostic reagents for immature cell analysis; medical and veterinary diagnostic reagents for hemoglobin analysis; medical and veterinary diagnostic reagents for reticulocyte analysis; medical and veterinary diagnostic reagents for erythrocyte analysis; medical and veterinary diagnostic reagents for nucleated red cell analysis; medical and veterinary diagnostic reagents for blood coagulation analysis; medical and veterinary diagnostic reagents for urinalysis; medical and veterinary diagnostic reagents for urinary sediment analysis; medical and veterinary diagnostic reagents for testing immunoassay; medical and veterinary diagnostic reagents for bacteria analysis; Reagents for clinical chemistry testing for medical or veterinary purposes; Diluents for blood samples, urine samples, bodily fluid samples or cell samples for medical and veterinary diagnostic purposes; medical and veterinary diagnostic reagents and solutions, namely, lysing solutions and reagents, and hemolytic lysing solutions and reagents; medical and veterinary diagnostic reagents and solutions, namely, sheath solutions; ] Reference control reagents for medical use; Hematology control materials for testing and calibrating medical apparatus and reagents; Hematology control materials for medical use; [ stain solutions for medical or medical diagnostic purposes; stain solutions for hematology analysis for medical or medical diagnostic purposes; stain solutions for reticulocyte analysis for medical or medical diagnostic purposes; stain solutions for urinalysis for medical or medical diagnostic purposes; stain solutions for immunoassay for medical or medical diagnostic purposes; and ] reference reagents for clinical laboratory tests for calibrating medical apparatus and reagentsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 6, 2023NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Mar 6, 2023RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Mar 6, 202389AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Mar 1, 2023E89RTEAS SECTION 8 & 9 RECEIVED—
Apr 9, 2022REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 9, 2019NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 9, 2019C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 9, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 1, 2019E815TEAS SECTION 8 & 15 RECEIVED—
Apr 9, 2018REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 9, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 6, 2013DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Mar 6, 2013AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 26, 2013IUCNNOTICE OF ALLOWANCE CANCELLED—
Feb 26, 2013D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Dec 4, 2012NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 9, 2012NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 9, 2012PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 19, 2012NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 4, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 3, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 6, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 30, 2012ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 26, 2012GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 26, 2012GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 26, 2012CNSISUSPENSION INQUIRY WRITTEN—
Jan 18, 2012RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 17, 2012ALIEASSIGNED TO LIE—
Jul 14, 2011GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 14, 2011GNSLLETTER OF SUSPENSION E-MAILED—
Jul 14, 2011CNSLSUSPENSION LETTER WRITTEN—
Jul 12, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 12, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 7, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2011DOCKASSIGNED TO EXAMINER—
Jan 13, 2011AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jan 11, 2011ALIEASSIGNED TO LIE—
Dec 10, 2010MAILPAPER RECEIVED—
Oct 13, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 11, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance